Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection

Although the COVID-19 pandemic began over three years ago, the virus responsible for the disease, SARS-CoV-2, continues to infect people across the globe. As such, there remains a critical need for development of novel therapeutics against SARS-CoV-2. One technology that has remained relatively unex...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Yuanyuan Qiao, Jesse W. Wotring, Charles J. Zhang, Xia Jiang, Lanbo Xiao, Andy Watt, Danielle Gattis, Eli Scandalis, Susan Freier, Yang Zheng, Carla D. Pretto, Stephanie J. Ellison, Eric E. Swayze, Shuling Guo, Jonathan Z. Sexton, Arul M. Chinnaiyan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897518/?tool=EBI